Parametric Portfolio Associates’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.09M | Sell |
11,136
-7,480
| -40% | -$734K | ﹤0.01% | 2739 |
|
|
2021
Q4 | $1.58M | Sell |
18,616
-8
| -0% | -$678 | ﹤0.01% | 2588 |
|
|
2021
Q3 | $1.49M | Buy |
18,624
+11,659
| +167% | +$930K | ﹤0.01% | 2607 |
|
|
2021
Q2 | $678K | Sell |
6,965
-392
| -5% | -$38.2K | ﹤0.01% | 2949 |
|
|
2021
Q1 | $861K | Buy |
7,357
+4,139
| +129% | +$484K | ﹤0.01% | 3233 |
|
|
2020
Q4 | $358K | Buy |
3,218
+959
| +42% | +$107K | ﹤0.01% | 3527 |
|
|
2020
Q3 | $268K | Buy |
2,259
+168
| +8% | +$19.9K | ﹤0.01% | 3535 |
|
|
2020
Q2 | $237K | Buy |
+2,091
| New | +$237K | ﹤0.01% | 3567 |
|
|
2018
Q4 | – | Sell |
-4,560
| Closed | -$976K | – | 3937 |
|
|
2018
Q3 | $976K | Sell |
4,560
-6,627
| -59% | -$1.42M | ﹤0.01% | 3112 |
|
|
2018
Q2 | $3.13M | Sell |
11,187
-3,236
| -22% | -$905K | ﹤0.01% | 2341 |
|
|
2018
Q1 | $1.68M | Sell |
14,423
-849
| -6% | -$99.1K | ﹤0.01% | 2730 |
|
|
2017
Q4 | $1.4M | Buy |
+15,272
| New | +$1.4M | ﹤0.01% | 2834 |
|
|
2015
Q4 | – | Sell |
-500
| Closed | -$30K | – | 3970 |
|
|
2015
Q3 | $30K | Buy |
500
+146
| +41% | +$8.76K | ﹤0.01% | 3250 |
|
|
2015
Q2 | $28K | Buy |
+354
| New | +$28K | ﹤0.01% | 3942 |
|
|
2015
Q1 | – | Sell |
-461
| Closed | -$43K | – | 3977 |
|
|
2014
Q4 | $43K | Buy |
461
+70
| +18% | +$6.53K | ﹤0.01% | 3953 |
|
|
2014
Q3 | $41K | Buy |
+391
| New | +$41K | ﹤0.01% | 3780 |
|
|
2014
Q2 | – | Sell |
-741
| Closed | -$112K | – | 3767 |
|
|
2014
Q1 | $112K | Buy |
741
+386
| +109% | +$58.3K | ﹤0.01% | 3733 |
|
|
2013
Q4 | $65K | Buy |
355
+54
| +18% | +$9.89K | ﹤0.01% | 3762 |
|
|
2013
Q3 | $67K | Buy |
301
+5
| +2% | +$1.11K | ﹤0.01% | 3750 |
|
|
2013
Q2 | $52K | Buy |
+296
| New | +$52K | ﹤0.01% | 3656 |
|